BASF Falls After JPMorgan Reiterates Underweight

JPMorgan analyst Chetan Udeshi said BASF’s second-quarter results included “special effects” and pointed to the company’s wide full-year guidance range as evidence of “low visibility” on whether positive trends will continue. That skepticism is landing in a fragile market: BASF stock was last down to 51.74 euros on Xetra, extending the pressure on a share that tends to trade heavily on the outlook for industrial demand rather than near-term earnings beats.

The broader issue for investors is that BASF still faces the same structural headwinds that have weighed on Europe’s chemical sector for years. Elevated energy, labor and regulatory costs are squeezing margins, while new capacity in China is adding pricing pressure across commodity chemicals.

BASF is trying to offset that with cost cuts, portfolio simplification and a large expansion in China at its Zhanjiang site. But JPMorgan’s stance suggests investors are not being asked to pay for a clean turnaround yet — only for the chance that the cycle improves faster than expected.

That leaves BASF’s next catalysts squarely tied to demand in its core end markets, utilization rates and margin progress, with China also a key test of whether growth can be translated into returns. If those data points disappoint, the underweight case is likely to stay in place.